Business
business

After getting rejected by Zyn, Tucker Carlson says he'll start his own brand

Tucker Carlson, the former Fox News host, said he will release his own brand of nicotine pouches after a kerfuffle with the maker of Zyn, the largest brand in the US. 

Carlson was a big fan of Zyn, so much so that he once said that he uses it “every second I’m awake.” As an unpaid promoter for Zyn, he led a growing right-wing, hypermasculine obsession for nicotine pouches. 

But his enthusiasm for the brand was so strong that it came with unfounded claims that it can treat erectile dysfunction, among other things. Philip Morris International, a legacy tobacco company that knows a thing or two about strict Food and Drug Administration rules on its industry, pushed back on Carlson’s statements, saying they “lack a scientific foundation.”

Carlson told the Journal that he was “just joking” when he made those claims. He then announced that he would start his own brand, Alp, in November. 

In an interview with the social media account Old Row, he said he was “embarrassed” that he used Zyn. He noted that Phillip Morris donates to Kamala Harris, the Democratic presidential nominee. (It has in fact donated $18,200 to her campaign.)

“It's good for your girlfriend, or whatever," Carlson said of Zyn. "I don’t think men should use that brand."

Using masculinity to market a product that isn't obviously gendered isn't new (See: Dude Wipes). But tobacco products require an FDA marketing order in order to be sold in stores. Even if Carlson secures one for Alp by November, the FDA takes unfounded medical claims pretty seriously, which is why Phillip Morris distanced itself from Carlson in the first place.

And with an army of masculinity-obsessed young men behind his product, what could go wrong?

But his enthusiasm for the brand was so strong that it came with unfounded claims that it can treat erectile dysfunction, among other things. Philip Morris International, a legacy tobacco company that knows a thing or two about strict Food and Drug Administration rules on its industry, pushed back on Carlson’s statements, saying they “lack a scientific foundation.”

Carlson told the Journal that he was “just joking” when he made those claims. He then announced that he would start his own brand, Alp, in November. 

In an interview with the social media account Old Row, he said he was “embarrassed” that he used Zyn. He noted that Phillip Morris donates to Kamala Harris, the Democratic presidential nominee. (It has in fact donated $18,200 to her campaign.)

“It's good for your girlfriend, or whatever," Carlson said of Zyn. "I don’t think men should use that brand."

Using masculinity to market a product that isn't obviously gendered isn't new (See: Dude Wipes). But tobacco products require an FDA marketing order in order to be sold in stores. Even if Carlson secures one for Alp by November, the FDA takes unfounded medical claims pretty seriously, which is why Phillip Morris distanced itself from Carlson in the first place.

And with an army of masculinity-obsessed young men behind his product, what could go wrong?

More Business

See all Business
business
Tom Jones

Demis Hassabis, Google DeepMind’s CEO and founder, was also an early Anthropic investor

A chess prodigy and an actual a knight of the realm in the UK, it’s perhaps no surprise that Demis Hassabis has made some strategic moves about his exposure to AI upside. According to people familiar with the matter, the influential AI architect became an angel investor in Anthropic, currently behind many of the leading AI models, per Arena AI leaderboards.

The Nobel Prize winner’s position in the Claude creator was previously undisclosed and, per the Financial Times, highlights Hassabis’ “growing influence across the AI industry.”

Google, which bought DeepMind, the company that Hassabis cofounded and heads to this day, for a reported ~$400 million in 2014, is also a key Anthropic investor. The tech giant reportedly plans to invest up to $40 billion in the AI company as part of the mutually beneficial relationship the pair have forged, with reports that Anthropic has committed to spending $200 billion in the other direction on Google’s cloud services over the next five years.

Im playing all sides, so I always come out on top

In addition to his financial support for Anthropic, Hassabis has also invested in a range of AI startups launched by colleagues, such as Inflection AI, a company set up by DeepMind cofounder Mustafa Suleyman (who is now CEO of Microsoft AI), as well as efforts from other collaborators, like David Silver’s Ineffable Intelligence.

Hassabis also emerged as a recurring figure on the fringes of the recent Elon Musk v. Sam Altman trial, cropping up repeatedly in testimonies and court documents and appearing to live, as The Verge put it, “rent-free” in Musk’s head.

Founded in 2021, Anthropic has recently raised funding at a reported $900 billion valuation, sending it soaring ahead of competitor OpenAI.

The Nobel Prize winner’s position in the Claude creator was previously undisclosed and, per the Financial Times, highlights Hassabis’ “growing influence across the AI industry.”

Google, which bought DeepMind, the company that Hassabis cofounded and heads to this day, for a reported ~$400 million in 2014, is also a key Anthropic investor. The tech giant reportedly plans to invest up to $40 billion in the AI company as part of the mutually beneficial relationship the pair have forged, with reports that Anthropic has committed to spending $200 billion in the other direction on Google’s cloud services over the next five years.

Im playing all sides, so I always come out on top

In addition to his financial support for Anthropic, Hassabis has also invested in a range of AI startups launched by colleagues, such as Inflection AI, a company set up by DeepMind cofounder Mustafa Suleyman (who is now CEO of Microsoft AI), as well as efforts from other collaborators, like David Silver’s Ineffable Intelligence.

Hassabis also emerged as a recurring figure on the fringes of the recent Elon Musk v. Sam Altman trial, cropping up repeatedly in testimonies and court documents and appearing to live, as The Verge put it, “rent-free” in Musk’s head.

Founded in 2021, Anthropic has recently raised funding at a reported $900 billion valuation, sending it soaring ahead of competitor OpenAI.

Latest Stories

Sherwood Media, LLC and Chartr Limited produce fresh and unique perspectives on topical financial news and are fully owned subsidiaries of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Money, LLC, Robinhood U.K. Ltd, Robinhood Derivatives, LLC, Robinhood Gold, LLC, Robinhood Asset Management, LLC, Robinhood Credit, Inc., Robinhood Ventures DE, LLC and, where applicable, its managed investment vehicles.